Abstract
Introduction
This research has sought to determine the problems with regard to the development of smart assistive powered wheelchairs such that one mass produced device can be used by a wide range of users, each with individual needs which may change over time. Whilst the principal of involving a wide range of stakeholder in order to identify problems and issues could be applied to the development of other assistive technology we have taken development of a smart assistive powered wheelchair as the core technology with the users and other stakeholders targeted towards this.
According to the UK Government, the term assistive technology is best described as a device which mitigates the effect of , such that the technology substitutes for some biological function which has been impaired [1] . The World Health Organisation (WHO) describes an daily activities es term for any device or system that allows individuals to perform tasks they would otherwise be [2] . The terminologies over time been driven towards meaning assistance which is more user centred, rather than terminologies with a wide definition referring to generic devices such as walking sticks and wheelchairs [3] . More recently the WHO have defined the assistive technology as a subset of health technologies which enable individuals to improve or maintain healthy, independent, and productive lives in a dignified manner whereas without they may become isolated and impoverished. Furthermore assistive products should be purposed to compensate for loss of ability and gradual decline in the individual over time whilst also reducing the burden on carers, health care providers, and welfare [4] .
Potential assistive technology users
The availability of the United Kingdom (UK) Census data makes it possible for estimates to be based on up-to-date demographic figures, which quote the UK population in 2011 as 56,075,912. A survey of disability in Great Britain, carried out by the Office of Population Censuses and Surveys (now the Office of National Statistics) in 1989, stated that 13.5% of the adult population of the UK had a disability of some kind, and that, of these, 69% had a mobility problem, these percentages correspond to the absolute figures of 7,570,248 and 5,223,471 respectively. The same source also estimated that 7% of disabled adults, and 10% of adults with a mobility problem used a wheelchair, and that 10% of those wheelchairs were of the powered type [5] .
The provision of a powered wheelchair (PWC) can have a significant impact on improving mobility, independence and quality of life. However not all persons who would benefit from the use of an PWC will meet the prescription criteria. For example, cognitive and visual deficit may exclude the individual. Additionally, even when prescribed with an EPW its use can be challenging, especially if the user does not have the required fine motor control for collision-free navigation within the home.
Operating a PWC indoors can present the user and their carers with significant challenges. Physical and mental disabilities can also make accurate control of the device a major challenge. Collisions with objects and people can be highly detrimental to the rehabilitation and confidence of PWC users, particularly if the independent use of the PWC is in jeopardy because an unacceptable risk level, which varies from prescriber to prescriber, has been reached.
Additionally, cognitive and physical ability will deteriorate with time for many PWC users. For example, users with Multiple Sclerosis or Motor Neurone Disease will have increasing physical difficulty in accessing and moving the joystick (the prime human machine interface) as well as being able to drive safely. This means that users with progressive conditions will require periodic assessment and adjustment of the PWC configuration in order to maintain independent and safe mobility. These adjustments to the control system mean the user often has to wait several weeks for appointments with clinicians, therapists, and technicians. The outcome can be that the user loses their independent mobility affecting their quality of life and that of their carers, friends and family.
One solution to this challenge is to develop a PWC control system which can measure the changes in user condition. This information can then be used to adapt the PWC control system to more closely match the ability of the user.
State-of-the-art
Over the past four decades considerable research has been published on the application of mobile robotic assistance to improve the quality of life for the disabled user [6] . According to a systematic review by Simpson [6] , it was observed that little attention had been paid to user input, user feedback, and user confidence, with esires. In order to investigate the importance of understanding those issues, research was carried out by Woods and Watson [7] . They suggested that a social constructionalist be undertaken in order to eeds and technological requirements and how society views the wheelchair and its user. It was important to question the assumption that the current social and technological solutions must automatically be the best.
There was a broad review of intelligent, or smart, and assistive PWC literature undertaken by
Simpson in 2006 [6] and another similar review by Faria in 2014 [7] . There have been some projects which have evolved or continued [8] - [11] and others initiated [12] - [15] ; between 2005 and 2013 over 4,000 papers were published; however no mass produced device has yet reached the end user, according to Garcia et al. [16] . They identified three major problems: that most research is undertaken in the Lab without involvement of the stakeholders, in particular the users; the lack of availability of suitable sensors; and lack of a standardised platform.
Another significant issue in the development of assistive PWC technology is the absence of any standard bench testing procedure so that research groups can compare the performance of their developments. In addition, when evaluating the performance of any assistive system it is essential to prove that the technological device is fit for purpose and safe [17] . Most research has not fully considered these issues [9] , [18] and what may be considered by some researchers as appropriate may not be , or worse may be considered dangerous when applied to realworld applications. Considering the somewhat complex requirements for keeping the individual user in overall control of the actions of the robotic PWC system, most research has concentrated on addressing specific issues rather than attempting to define the wide-ranging problem and work towards a solution which balances the global variables.
We have worked closely with one of major suppliers of PWC control systems, Dynamic
Controls Ltd. The manufacturer informed us that the problem is essentially profit and cost such that the larger the market and the simpler the device the lower the cost, in the case of the assistive technology powered wheelchair we find ourselves with the exact opposite: complex unique to the individual, or bespoke, equipment. Dynamic Controls Ltd states that without external funding they would be unable to develop the required technologies; quite simply they would lose money if they did attempt to do so.
The aim of this research
The road to developing assistive technology, which is fundamentally a user specific adaption of some technology, and making it mass producible for a wide range of users is likely to be a very complex and costly one. If, the past 40 years, research into producing a smart assistive powered wheelchair has still failed to provide anything but the most basic line following navigation assistance [19] , then the challenge of developing adaptive smart assistive systems will need to be approached very differently. Referring back to the approach we hypothesise that in order to develop a technology that can be adapted, adjusted, and applied to a wide array of user needs, there needs to be a commonly acceptable (amongst all stakeholders) range of functionality which per unit cost.
This research is an attempt to start at the beginning of the development process by trying to understand the relationship between stakeholders and their views on the development and use of assistive technology. This will identify some of the reasons why the route of developing assistive technology and getting it to the end user appears to be so problematic. There is also clearly a need to identify a methodology which can be used to develop cost-effective assistive technology.
Methodology
Literature is sparse with regard to PWC stakeholder semantics and the variation of difference in definition for each of the stakeholder classes. Therefore, in order to understand the interclass relationship and to obtain some measure of the range of functionality common to stakeholders we devised a simple questionnaire (see appendix A) which we could circulate to relevant stakeholders.
The questions were based upon significant experience gained by the authors due their extensive involvement in two European Union projects developing powered wheelchair assistive technology, SYSIASS [20] and COALAS [21] . A follow-on European Union cluster project called EDECT [22] involved the organisation of a stakeholder conference and the undertaking of a user clinical evaluation of assistive technologies. It was during the stakeholder conference that some of the questionnaires were first circulated to collect data in a semi-structured manner, with the stakeholders completing the form themselves having had the questions explained. Data was also collected from stakeholders at the 2016 Naidex exhibition [23] in Birmingham, UK and at the 2016 Independent Living Scotland exhibition [24] where again the questions were explained and the responses self registered.
Questionnaire
The questionnaire was designed with questions worded in such a way as to encourage the stakeholder to reflect on their own opinion, rather than any generally accepted view, by specifically directing the questions at the reader. This was re-enforced with instructions, written and verbal, on how to answer the questions. There were a total of 12 questions with a rating scale of 1-10, where 1 denotes no, less, or not much and where 10 rates as yes, greatly, very much, or lots . There was an additional section for responders to add their personal comments, Questionnaires were handed out in person with an explanation of what was required and why the information was required to the following groups of stakeholders:  Academic; university or hospital teaching/research.  Researcher; university or hospital research.
 Student; university or hospital student on relevant nursing/caring/medical course.
 User; those using powered wheelchairs and other devices.
 Prescriber; occupational therapist/other who directly prescribes PWCs/assistive technology.
 Clinician; hospital medics whose patients use PWCs and other devices.
 Carer; person who is involved in the daily care of users.
 Policymaker; someone who has political decision making in hospitals/governing bodies.
Participants were asked to indicate with which stakeholder group in the assistive technology field they were most strongly affiliated. More than a hundred forms were issued and seventy-four stakeholders responded. 
How much do you feel that other stakeholders in assistive technology provision understand
In this question, we were attempting to ascertain the general feeling amongst stakeholders about how they thought their fellow stakeholders really 
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This research was subject to U K standard ethical review process for projects involving human participation, and met all of its requirements.
Data analysis
Due to the consideration that the data is nonparametric in behaviour, P C which measures the linear correlation between two variables [26] , and " ' gives a measure of nonparametric rank correlation [27], and Wilcoxon Signed-Rank Test [28] employed for analysing matched-pair data based upon difference; were used to test for consistent differences/similarities in agreement between stakeholder groups, whilst we utilised F 
Results

F K
Despite some groups of stakeholders having a relatively low number of participants the result of the It may be inferred from the mean value of responses in Figure 1 that the responders/raters wrongly took the question to mean the value of the contribution the user can make towards developing assistive technology steered by the end user. Although one user, one researcher, and one carer clearly understood the question and gave a middle rating indicating that they thought that the development was a process for the involvement of other stakeholders. Therefore the ratings were very densely centred on the maximum value with one clinician declining to answer this question. The prescribers ( Figure 8 ) had a high rating with a low range; the only other stakeholders with similar ratings were the clinical students ( Figure 5 ). All other stakeholders had a very wide range of ratings although generally more positive than question 2, with the all group mean of the medians One prescriber failed to rate this question.
Question 4:
The response to this question was for all stakeholders to rate this highly with the mean median rating ( Figure 2 ) just under nine.
Question 5:
The ratings showed that the clinicians, prescribers, and policymakers were rating this question more positively than the remaining stakeholders, particularly users ( Figure 6 ) and carers ( Figure 9) ; this question rated an average median over eight and was closely grouped around that value.
Question 6:
The ratings were a little less compact in the responses to this question but still almost the same overall average median of all groups as were the previous two questions (4 and 5), see Figure 2 , making the block of three questions (4-6) results appear correlated. The only question out of the block of three (4-6) which stakeholders failed to answer was this question which was left blank by three users. From one comment section it was clear that they not think the question applied to them, although users had been told to simply replace the word user with other stakeholder such as a carer if they were physically able to partake, three users rated the question with a score of ten.
The response to this question indicates that the concept of role-reversal to better understand the problems seems to appeal to all stakeholders, however; the meaning/use may need clarification.
Question 7:
The ratings were very wide spread, being based upon stakeholders own experiences. The user group had the widest spread of responses with the clinicians (Figure 10 ), students, and policymakers having the narrowest. The researchers, users, carers, and students general opinion was that the technology would make users feel less isolated; however the policymakers, followed by the clinicians and then the academics were more sceptical. This was the most unanswered question, two policymakers, one clinician, one user, one student, and four academics left the answer blank.
Question 8:
It was clear from the responses that all of the stakeholders took the question seriously, except one academic and one policymaker who failed to rate. The academics having the most positive rating followed by the younger students, the clinicians, prescribers, and the policymakers were similarly grouped although being generally negative ( Figure 7) . The answer to this question clearly straddled the midway point with a clear divide between the innovators of new technology and those who need to apply and prescribe the technology to the end user. The question may also need rephrasing.
Question 9:
The students recorded a wholly positive rating in their agreement with the question, followed by the prescribers; in contrast the researchers were wholly negative with their rating of the question. All other stakeholders were scoring around the centre of the range of rating values. One user and one carer chose not to record their answer to the question.
Question 10:
This question seeks to clarify opinions on the issue of whether cost is an issue, the wording being carefully chosen to imply the cost of the end product rather than front end costs such as research. The very high median value of nine for all stak Figure 1 indicates a general consensus that end cost is a major issue, although some stakeholders notably the researchers thought otherwise, they were very much spread around the middle of the ratings with their mean at five being slightly negative. The prescribers were the next group to be less sure that cost was the issue having a mean at between seven and eight followed by the user mean at eight.
These groups (researchers, users, prescribers) also had a very large spread of ratings compared to all the other groups who were much tightly bound to the upper end of the scale. Only one prescriber failed to respond to this question.
Question 11:
Policymakers and prescribers were closely bound to the upper ratings between eight and ten with a median over nine for both groups. These two were followed very closely by the researchers with a mean of nine and a range of seven to ten. The user group had a mean close to ten with a tight central range between the upper and lower quartiles around the median, although one user rated this category at three, which may indicate that they misunderstood the question or had some other personal reason. The remaining stakeholders all had a much wider spread of ratings although their medians were all above eight in the ratings; this question was answered by all 74 stakeholders.
Question 12:
The results showed the overall stakeholder median rating was the third highest for all questions, and the mean rating for all stakeholders was nine. The academics, researchers, and students had a wider range of ratings with a median generally slightly lower than the other stakeholders. The clinicians, users, and prescribers had high median ratings and were very closely grouped at the more positive end; the policymakers did not answer the question. 
P C
Academics have better than a 0.81 (Table 3 ) correlation with users, prescribers, and carers, which demonstrates the general good understanding academics have of the problems faced by the users.
The researchers have the closest correlation with the user group at 0.95 followed by clinicians at 0.9, the prescribers 0.89, then the carers 0.88, with the remaining stakeholders all better than a 0.75 correlation. The policymakers clearly have a poor correlation with students at 0.57 and prescribers second worse at 0.7 with a much better correlation between users 0.84, clinicians 0.85, and carers at 0.84. This may however be more of a reflection of the likelihood of the different stakeholder groups meeting each other and interacting. 
According to the results given in Table 4 , the group of academics have an agreement correlation rank of ' highest correlation of agreement with users at 0.94, clinicians 0.91, and prescribers 0.9 and all others greater than 0.79 making them the group with the best statistical fit to all the other groups.
The agreement between students and policymakers, and also with prescribers, showed a poor correlation at 0.64 and 0.65 respectively. Resear T academics 2 ( Table 5 ). The lower the number in this test, the stronger the correlation between two sets of data; this means that the researchers have a very close statistically significant opinion with all stakeholders except students and academics. The clinicians, clinical students, and carers, seem T policymakers have a good pairing with clinicians and an even better pairing with academics but a poorer paring with prescribers and users. Academics have their best pairing with researchers, followed by the clinicians at 7.5, but a worse pairing with the user and prescriber groups. Users have their best pairing with researchers and second best with carers at 5.4 then prescribers. 
Discussion
When each group of s responses were averaged the range of all the groups when combined had a significant clustering, as shown in Figure 2 , despite the wide range of individual ratings within each group shown in Figure 1 . This indicates that there is a general trend with the responses to the questions which means we have identified some common ground amongst the stakeholders. Not answering a question could have been lack of experience in a certain area making them feel unable to give an opinion, lack of understanding of the question or did not feel the question applied to them and so left the question blank.
The response to question one clearly places the concept of user involvement in the process of assistive technology development as being of paramount importance. However from the wide range of ratings to question two, and particularly the common mean trend rating of six (Figure 2 ), we can deduce that although individuals may have differing personal experiences that there is a clear lack stion three then we can say that the user is not as involved in the entire assistive technology process as much as stakeholders think they should be.
The second block of questions had a distinct objective to determine stakeholder views on the method of role reversal simulation to help them better understand the problems, and whether the concept would be taken up by stakeholders as a methodology. The responses from all raters suggest that the concept is one which would be acceptable, although due to the slightly less enthusiastic response to question six possibly not compulsory.
The responses to the third block of questions (7) (8) (9) were wide ranging and the common trend was centred close to the middle rating. Whilst it would be easy to assume that raters misunderstood these questions, or that there was a general middle-of-the-road response, when we examine the inter-group rating ranges there are distinct differences. Question seven asked whether technology would make users feel more or less isolated from society, the responses from the user group closely matched the median range of all the stakeholder groups combined. However there was a distinct split between clinicians and policymakers who thought users would become more isolated and researchers and students who thought that technology would make users less isolated. We surmise that this may be due to age and the younger stakeholders being more comfortable with social media and the wider opportunities for socialising that this brings; conversely older and severely disabled users may not understand or be comfortable using such technology, the professionals being aware of this problem.
Question eight was aimed at determining the simplistic view of whether stakeholders believed
The assumption was that the technologists would have a neutral view around the rating of five to six and for the users, carers and medical Although the technologists were tightly clustered close to centre point as expected, the response from the researcher group was wholly on the negative side of the centre point whereas the academics were wholly on the higher positive side. Most of the other stakeholder groups each had a wide range of ratings, some spanning the whole spectrum of ratings, with their median response at the mid-point.
The policymaker median was slightly more positive and the user group median more negative. The responses appear to support our hypothesis suggesting that the problems and solutions might be divided between social and technological and therefore assistive technology development should consider the social impact.
The next question and the last in this third group of questions sought to establish how far advanced different stakeholders thought academia was with progress towards providing solutions to empower users to a level they would desire. The researchers were wholly negative and the students wholly positive with the academics nearly all on the positive side of the centre point. The prescribers were also mainly positive with their median rating of six. All of the other stakeholders were widely ranged but with their medians centred towards the mid-point. The implication here is that academics, prescribers, and the clinical students have a belief that academia is reasonably advanced with regard to providing solutions where in reality, as stated previously, little has been brought to market because of the complex problems which need to be overcome, as the researchers low ratings imply.
Stakeholders mostly rated question 10 does cost restrain the development and adoption of new technology towards the maximum rating which makes this the second highest rated question after number one. The academics, carers, and policymakers all had a median rating of nine firmly holding the opinion that cost was the driving force. Most other groups had their median rating at either seven or eight with the exception of the researchers who had their median slightly negative at five and their quartile range between three and eight making this group appear to imply that cost was only one factor rather than the driving force, some users, clinicians, prescribers, and policymakers widened their respective group spread of ratings towards the centre point supporting this notion. When we analyse the inter-group correlations we might expect that academics would have a close pairing with their researchers and also a good pairing with clinicians, particularly as medical research projects involve collaboration between academics and clinicians. We would also expect academics not to frequently meet users as their researchers would be an intermediary; furthermore they would very infrequently meet prescribers and therefore share even less in common with this group.
Researchers have the closest pairing to all groups, which we would expect to be the case, as they are working and communicating with all stakeholders and knowledgeable within the art in a specialised way. Policymakers, academics, clinicians, and researchers are also likely to meet and discuss research projects, particularly in light of funding applications; therefore the pairings shown in this test are closer between these groups. The policymakers probably have little chance to meet users, carers, and students hence the worse pairings are with these groups. Despite small differences, in general this test has also confirmed that all stakeholders appear to have a reasonably good common understanding of the challenges underlying the questions in the questionnaire.
Conclusions
From this research it is clear that for assistive technologies to be effectively deployed they must, in s, be supported by providing:
 Specific role reversal or immersion into other stakeholder environments during training to use the technology for prescribers and carers, and in general for all stakeholders when the technology is first being developed in order to better understand the problems.
 Feedback from the user about, and ongoing monitoring of, their quality of life when using the technology, to all other stakeholders, and in particular technicians and clinicians.
 Ongoing training (re-training) and technical support should be readily available to users and other stakeholders to ensure the devices do not become discarded or damaged and remain fit for the purpose they were designed.
 Better social and professional interaction should take place between stakeholders to share knowledge and exchange experiences rather than remain isolated in their respective groups.
 A consideration for funders must be the need for the involvement of all the stakeholders in assistive technology research together with a strong industrial partnership if these devices are to reach the end user.
Furthermore, we conclude that any methodology for improving the uptake of technology into the market place and onto the end user should involve the following:
 engaging assistive technology users, and all other stakeholders, in regular discussion to determine the problems that require solutions, and also iteratively evaluate these solutions during development phases of the equipment;
 establish if there is a grouping of many user problems which can be solved by one type of adaptable and adjustable device;
 determine the number of users and undertake a typical marketable device cost-benefit analysis with involvement of the manufacturer;
 obtain public funding with a manufacturer in partnership to undertake the research;
 involve all stakeholders in the development and evaluation of the device.
Finally, we concluded that the device should:
 decrease user isolation;
 be capable of being monitored for determination of the improvement in the quality of life;
 have ample technical support and training;
 be cost effective;
 be adjustable and adaptable to a wide range of users;
 be easily operated by anyone;
 have a suitably adjustable and adaptable interface if necessary.
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